Sequent Scientific Limited

Informe acción NSEI:SEQUENT

Capitalización de mercado: ₹30.0b

Salud financiera de hoja de balance de Sequent Scientific

Salud financiera controles de criterios 4/6

Sequent Scientific tiene un patrimonio de los accionistas total de ₹6.8B y una deuda total de ₹4.6B, lo que sitúa su ratio deuda-patrimonio en 67.5%. Sus activos y pasivos totales son ₹15.0B y ₹8.2B respectivamente.

Información clave

67.5%

Ratio deuda-patrimonio

₹4.61b

Deuda

Ratio de cobertura de interesesn/a
Efectivo₹598.81m
Patrimonio₹6.83b
Total pasivo₹8.18b
Activos totales₹15.01b

Actualizaciones recientes sobre salud financiera

Recent updates

Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Apr 05
Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Mar 10
Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

Jan 31
Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Jan 17
How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

Jan 05
Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Dec 24
What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Dec 12
Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Nov 22
Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

Nov 10
Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

Oct 20
The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Oct 05
How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Is Sequent Scientific Limited's (NSE:SEQUENT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Sep 04
Is Sequent Scientific Limited's (NSE:SEQUENT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Sequent Scientific's (NSE:SEQUENT) Earnings Warrant Your Attention?

Aug 20
Do Sequent Scientific's (NSE:SEQUENT) Earnings Warrant Your Attention?

Sequent Scientific Limited's (NSE:SEQUENT) Earnings Haven't Escaped The Attention Of Investors

Jul 30
Sequent Scientific Limited's (NSE:SEQUENT) Earnings Haven't Escaped The Attention Of Investors

Does Sequent Scientific (NSE:SEQUENT) Have A Healthy Balance Sheet?

Jul 10
Does Sequent Scientific (NSE:SEQUENT) Have A Healthy Balance Sheet?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹7.7B) de SEQUENT superan a sus pasivos a corto plazo (₹6.0B).

Pasivo a largo plazo: Los activos a corto plazo de SEQUENT (₹7.7B) superan a sus pasivos a largo plazo (₹2.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de SEQUENT (58.8%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de SEQUENT ha crecido de 40% a 67.5% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable SEQUENT tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: SEQUENT no es rentable, pero tiene suficiente cash runway para más de 3 años, incluso con un flujo de caja libre positivo que se reduce un 34.6% al año.


Descubre empresas con salud financiera